|Articles|June 16, 2010

FDA Clears Aesculap SterilContainer S System for use in the STERIS Amsco V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems

Aesculap, Inc. announces that the SterilContainer S product line has been cleared by the United States Food and Drug Administration (FDA), (510(k) number, K093649) for use in the STERIS Corporation’s V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems.

“Maximizing ROI is key in today’s economic environment,” said Edward Nuber, product manager of sterile technology at Aesculap Inc. “Healthcare facilities can reduce repair cost while maximizing set utilization by securing heat and moisture-sensitive instruments in the Aesculap SterilContainer S system during processing in the V-PRO™ 1 and V-PRO™ 1 Plus Systems.”

The Aesculap SterilContainer S is a reusable, environmentally friendly, rigid container system used for the packaging, transportation, and storage of instruments prior to, during and after sterilization. The SterilContainer S product line consists of Full, Three Quarter, Half and Extra Long Mini size SterilContainers, instrument baskets, filters, indicator cards, tamper proof locks, silicone mats, and the Aesculap Instrument Organization System.

The V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems can quickly process high volumes of heat and moisture-sensitive devices using vaporized hydrogen peroxide, an environmentally friendly sterilant. In addition to the single 55-minute automated cycle of the V-PRO 1 system, the new V-PRO 1 Plus sterilizer includes a second 28-minute cycle specifically for sterilizing non-lumened devices. This allows operators to enhance productivity by choosing the cycle that best matches the devices being sterilized. Both systems have a one-touch control that requires minimal training, and both are equipped with remote monitoring capabilities for increased uptime.


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.